LifeVantage Corporation: Business Overview, Financials & Competitive Analysis
LifeVantage Corporation scores 6/10 on the AskCyborg Cyborg Score (Solid). Growth-stage nutraceutical company showing revenue acceleration and attractive valuation, leveraging emerging GLP-1 category tailwinds and international expansion. Revenue was $58.4 million, an increase of 21.1% from the prior year period in Q3 FY2025, demonstrating growth momentum. LFVN's valuation is attractive at ~6x EV/EBITDA and a Fwd PEG of 0.15x, trading.
What is LifeVantage Corporation's industry? LifeVantage Corporation (lifevantage.com) operates in Nutraceuticals & Dietary Supplements / Direct Sales / Nutrigenomics. AskCyborg classifies LifeVantage Corporation under Nutraceuticals & Dietary Supplements / Direct Sales / Nutrigenomics in its company registry.
LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new science dedicated to cracking the human aging code. The company engages in the identification, research, development, formulation, and sale ...
Cyborg Score thesis
Growth-stage nutraceutical company showing revenue acceleration and attractive valuation, leveraging emerging GLP-1 category...
Read the full analyst-debate transcript →Get the Latest LifeVantage Corporation Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeLifeVantage Corporation Overview
Pro stress-test →LifeVantage Corporation (Nasdaq: LFVN) is a pioneer in Nutrigenomics - a new science dedicated to cracking the human aging code. The company engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products. It sells its products through its website and network of independent consultants.
Strategic Profile
Pro stress-test →The company's revamped business model and compensation package have increased active accounts by 25%, indicating early signs of success turnaround and enhanced sales outreach. The company is extending its groundbreaking MindBody GLP-1 System™ to international markets after a 49% year-over-year increase in fiscal Q2 revenue ending December 31, 2024, in the U.S., largely driven by the system's success. LifeVantage leverages a direct sales model with a growing distributor network focused on scientifically-backed cellular health solutions.
Competitive Landscape
Pro stress-test →The balanced integration of research, product development, and an extensive consultant network positions LifeVantage as a respected entity within the nutraceutical landscape. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, Spain, Ireland, Singapore, and the Philippines. Primary competitors include larger diversified supplement companies (NBTY, USANA) and specialized direct-sales nutraceutical firms.
Industry Context
LifeVantage Corporation operates in Nutraceuticals & Dietary Supplements / Direct Sales / Nutrigenomics.
Key facts
Founded: 2003 · Headquarters: Lehi, Utah, United States · Revenue: $58.4M (Q3 FY2025) · Market cap: $~160M